购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • HSP
    (1)
  • Others
    (9)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 5日内发货
    (4)
  • 35日内发货
    (1)
  • 6-8周
    (2)
筛选
搜索结果
TargetMol产品目录中 "

neurodegenerative disorder

"的结果
  • 抑制剂&激动剂
    12
    TargetMol | Inhibitors_Agonists
  • 化合物库
    1
    TargetMol | Compound_Libraries
  • 重组蛋白
    4
    TargetMol | Recombinant_Protein
  • 多肽产品
    2
    TargetMol | Peptide_Products
  • 天然产物
    1
    TargetMol | Natural_Products
  • 疾病造模
    1
    TargetMol | Disease_Modeling_Products
  • Gedunin
    葛杜宁
    T218832753-30-2
    Gedunin 是从印楝种子中提取的一种重要柠檬苦素,具有抗癌、抗病毒、抗炎和杀虫活性。它可阻断 SARS-CoV-2 病毒进入人宿主细胞,用于 COVID-19 研究。它是Hsp90抑制剂,诱导 Hsp90 依赖的蛋白降解,抑制卵巢癌细胞增殖。
    • ¥ 3320
    现货
    规格
    数量
  • (Rac)-Neurodegenerative Disorder-Targeting Compound 1
    T835271254699-12-1
    (Rac)-Neurodegenerative Disorder-Targeting Compound 1为一种针对神经退行性疾病的化合物,具有calpain抑制活性。
    • 待询
    8-10周
    规格
    数量
  • Neurodegenerative Disorder-Targeting Compound 1
    T134861254698-39-9
    Neurodegenerative Disorder-Targeting Compound 1 是一种靶向 calpain 的抑制剂。
    • ¥ 10600
    8-10周
    规格
    数量
  • 3β,5α,6β-Trihydroxycholanic Acid
    T8498816030-92-5
    3β,5α,6β-Trihydroxycholanic acid, a metabolite derived from 5α,6β-dihydroxycholestanol, exhibits elevated levels in dried blood spots of patients diagnosed with Niemann-Pick disease type C, a neurodegenerative disorder characterized by the accumulation of cholesterol and sphingolipids in lysosomes.
    • 待询
    8-10周
    规格
    数量
  • KMS88009
    KMS-88009, KMS 88009
    T242651089681-42-4
    KMS88009 is an amyloid-β aggregation inhibitor that acts by ameliorating neurodegenerative disorder.
    • ¥ 10600
    6-8周
    规格
    数量
  • β-Amyloid (11-22)
    β-Amyloid 11-22
    TP1673885323-98-8
    β-Amyloid (11-22) is a peptide fragment of β-Amyloid. Beta-amyloid peptide (Abeta), the primary component of amyloid plaques in the brains of Alzheimer’s patients, is believed to be the cause of Alzheimer’s Disease (AD), the most common neurodegenerative disorder.
    • 待询
    规格
    数量
  • brd3731
    T615782056262-07-6
    BRD3731 is a selective inhibitor of GSK3β, demonstrating an IC50 value of 15 nM for GSK3β and 215 nM for GSK3α. Due to its inhibitory properties, BRD3731 holds promise for investigating various medical conditions, including post-traumatic stress disorder (PTSD), psychiatric disorders, diabetes, and neurodegenerative disorders [1].
    • ¥ 2990
    5日内发货
    规格
    数量
  • C20 Sphingomyelin (d18:1/20:0)
    T35809121999-68-6
    C20 Sphingomyelin is a naturally occurring sphingolipid. Levels of C20 sphingomyelin are upregulated in the hippocampus of rats with diabetes induced by streptozotocin and in human plasma where it is positively correlated with insulin resistance in obese humans. C20 sphingomyelin is also upregulated in the liver of a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder. The plasma concentration of C20 sphingomyelin is decreased in men with prostate cancer.
    • 待询
    规格
    数量
  • β-Amyloid (1-40) (TFA)
    T75751
    β-Amyloid (1-40) TFA 是阿尔茨海默症患者脑斑块中发现的一种主要蛋白片段。
    • 待询
    规格
    数量
  • Mu-6S-Palm-β-Glc
    T37191229644-17-1
    Mu-6S-Palm-β-Glc is a fluorogenic substrate of palmitoyl-protein thioesterase (PPT, also known as CLN1), a lysosomal hydrolase that removes long-chain fatty acyl groups from modified cysteine residues in proteins. Mu-6S-Palm-β-Glc is cleaved by PPT CLN1 to release the fluorescent moiety 4-methylumbelliferyl (4-MU). 4-MU fluorescence is pH-dependent with excitation maxima of 320 and 360 nm at low (1.97-6.72) and high (7.12-10.3) pH, respectively, and an emission maximum ranging from 445 to 455 nM, increasing as pH decreases. This substrate is used in assays that measure PPT activity, which is commonly deficient in the neurodegenerative disorder known as infantile neuronal ceroid lipofuscinosis.
    • ¥ 2245
    35日内发货
    规格
    数量
  • C16 Lactosylceramide (d18:1/16:0)
    T358044201-62-1
    C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder.
    • ¥ 7580
    期货
    规格
    数量
  • mHTT-IN-1
    T732892839311-21-4
    mHTT-IN-1 (Example 1) 为针对突变亨廷顿蛋白 (mHTT) 的高效抑制剂,该蛋白具毒性,主导遗传性常染色体显性神经退行性疾病—亨廷顿氏病 (HD) 的发生。mHTT-IN-1 能有效降低 mHTT 水平,其 EC50 值为 0.46 nM。
    • ¥ 10600
    期货
    规格
    数量
没有更多数据了